683 Capital Management’s TScan Therapeutics TCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-43,198	Closed	-$252K	–	238
2023 Q4	$252K	Buy	+43,198	New	+$252K	0.02%	135